Tag: COVID-19
AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention
AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More
Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment
Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More
US NIH stops ACTIV-2 phase 3 trial of Covid-19 drug candidate SAB-185
SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial of the company’s SAB-185 for the treatment ... Read More
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More
Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio
Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More
Hinduja Global Solutions bags contract worth up to £211m from UKHSA
Hinduja Global Solutions (HGS) said that its subsidiary HGS UK has bagged a contract worth up to £211 million (INR 2,100 crores) from the UK ... Read More
Lilly, US govt sign deal for 600,000 doses of Covid-19 drug bebtelovimab
Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of ... Read More
Australia’s Talon Energy to exit from UK North Sea exploration
Talon Energy said that it has decided to launch an exit of its portfolio of exploration assets in the UK North Sea based on an ... Read More
Novavax reports success for NVX-CoV2373 in pediatric group of phase 3 trial
Novavax said that its Covid-19 vaccine NVX-CoV2373 achieved its primary effectiveness endpoint in the pediatric expansion of its phase 3 PREVENT-19 trial. According to the ... Read More
Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More